Sleeping Aids Market Size & Share Analysis - Emerging Trends, Growth Opportunities, Competitive Landscape, and Forecasts (2025 - 2032)

Sleeping Aids Market Trends and Drivers

Growing Adoption of Wearable Monitors and Sensors Is Key Trend

• The growing adoption of wearable monitoring devices and sensors is one of the key drivers for the global market.
• These devices help record and transmit data related to various physiological conditions, for monitoring and measuring the sleep quality.
• Some of the wearable monitors and sensors available are Sense Wear Armband by Jawbone, BioHarness by BIOPAC Systems Inc., LifeShirt by Aegis Limited, Zio XT by iRhythm Technologies Inc., and LifeVest by ZOLL Medical Corporation.
• They are designed to record data about a person's sleep in their natural environment over a long period.
• In order to quantify aspects such as sleep/wake cycles, end users are increasingly employing wearable gadgets.
• Moreover, these wearable monitors and sensors are easy to use and do not require any special skill to operate them, thus making them popular among patients suffering from such disorders.
• Therefore, with the rising support for the usage of such instruments to monitor sleep health, the demand for sleeping aids is expected to grow.

Rising Incidence of OSA and Insomnia Drives Market

• The market for sleeping aids is majorly driven by the increasing incidence of obstructive sleep apnea (OSA) and insomnia (sleeplessness).
• As per studies, OSA affects 9–38% of the people in the world, while up to 60% suffer from insomnia.
• Anxiety, stress, and depression are some of the most common causes of chronic insomnia.
• OSA, RLS, periodic limb movement disorder, and insomnia are some of the common sleep disorders that lead to chronic insomnia.
• According to the American Sleep Apnea Association, more than 50 million Americans already suffer from over 80 different sleep disorders, and 20 to 30 million suffer from intermittent sleep problems each year.
• Further, insomnia is the most common specific sleep disorder, with short-term issues reported by about 30% and chronic insomnia by 10%, of the adults in the country.
• Insomnia and OSA cases require treatment that involves sleeping aids, which, in turn, is driving the growth of the global sleeping aids market.

Increasing Sleep Disorder Awareness Could Offer Opportunities

• Various government and non-government organizations are spreading awareness about the importance of proper sleep and usage of sleeping aid products.
• For instance, Philips has extended its sleep camps and launched a Center of Excellence for training on diagnosing sleep disorders in major Indian cities.
• This move is aimed at increasing the awareness about sleep disorders across the country.
• Moreover, the National Healthy Sleep Awareness Project promotes improved sleep health in the U.S., by increasing public awareness about the importance of healthy sleep.
• The organizations promoted the treatment and prevention of sleep disorders.
• In addition, the American Sleep Medicine Foundation is involved in increasing the awareness about sleep disorders.
• Furthermore, the American Sleep Apnea Association, a non-profit organization founded in 1990, is focused on increasing the awareness about sleep disorders and promoting sleep medicine research.
• The organization’s initiative has become a medium for educating physicians, patients, and other healthcare professionals about good sleep health and sleep products.
• Further, World Sleep Day, a global initiative for spreading awareness among people, by educating them about the importance of sleep, is celebrated on March 13 every year.
• Thus, the increasing initiatives to raise the awareness about the importance of adequate sleep and sleep disorders are creating opportunities for the market players, globally.

Sleeping Aids Market Segmentation and Category Analysis

Offering Analysis

Mattresses and pillows held the largest share, of 45%, in 2024. A wide variety of mattresses and pillows developed by local as well as international manufacturers is available around the world. Moreover, these products are cost-effective, which leads to their wide adoption among the population.

With an increasing number of people suffering from sleep disorders in China, companies such as Xilinmen and Xiaomi are putting more efforts into scientific research and development to offer better products. Moreover, players are focusing on exploring the potential effects of advanced technology on sleep time. For instance, Pillow Cube has launched the Dream Machine, under its Pillow Cube brand. The product utilizes AI to adjust to sleep. It detects stimuli from outside the patient’s body and leverages machine learning to create an environment that can aid in optimal sleep, by playing sounds that people find soothing and detecting snoring.

The sleep apnea devices category will witness the fastest growth during the forecast period due to the rising prevalence of OSA. Additionally, the development of advanced devices for its management, especially CPAP devices, drive the market. They consist of a pump and a mask connected through a tube and are mostly used by sleep apnea patients to reduce severity of sleep disorders. They also provide relief from snoring and offer uninterrupted sleep. Moreover, full-face masks, use of soft material, and masks that cover only the nose reduce snoring, thus fueling the demand for advanced CPAP devices. Several market players offer different types of CPAP devices, such as in-CPAP humidifiers, which keep the air inside the device moist. Moreover, the CMS covers a three-month trial procedural cost of CPAP therapy devices if a person has been diagnosed with OSA.

These offerings have been analyzed:

• Mattresses and Pillows (Largest Category)
• Sleep Laboratory Services
• Medication
  • Prescription drugs
  • Over-the-counter (OTC) drugs
  • Herbal remedies
• Sleep Apnea Devices (Fastest-Growing Category)
  • Positive airway pressure (PAP) devices
  • Facial interface
  • Oral appliances
  • Adaptive servo-ventilators (ASVs)
  • Others
• Others

Sleep Disorder Analysis

Insomnia is the largest category, on account of the rising incidence of sleeplessness. Additionally, several remedies are suggested for this condition, including those people can easily do at home and those offered as a service. The latter include exercise and customized nutrition plans, which a large number of people choose. Additionally, OTC sleeping pills are easily available at pharmacies and online and, thus widely consumed. Further, as per studies, a large number of people, including addicts, self-prescribe sleeping pills, which also leads to the dominance of this category.

The sleep apnea category is projected to witness the fastest growth during the forecast period. This will mainly be on account of the widespread burden of OSA, rising geriatric population, and development of technologically advanced portable sleep apnea devices. As per an article published in the News Medical Lifesciences portal in July 2020, the majority of the OSA cases remain undiagnosed, because symptoms are sometimes mild and there is a lack of resources in diagnostics. Therefore, to resolve the issue, Finnish computer science students designed an Android application, ApneaTracker, which monitors the user's snoring through a microphone, using the sensors of a smartphone or smartwatch.

These sleep disorders have been analyzed:

• Insomnia (Largest Category)
• Sleep Apnea (Fastest-Growing Category)
• Restless Legs Syndrome (RLS)
• Narcolepsy
• Sleep Walking
• Others

Sleeping Aids Market Geographical Analysis

Globally, the North American market held the largest share, of 40%, in 2024. The dominance of the region can be primarily ascribed to the growing incidence of sleep disorders and the initiatives and other forms of support of government and non-government organizations for increasing the awareness about the associated disorders and sleep hygiene.

As per the Sleep Foundation, in Camden, New Jersey; and Detroit, Michigan; around 49% of the adults report having trouble sleeping. Additionally, the approval of effective drugs is boosting the market's expansion. The FDA has approved fexinidazole as an oral treatment for both stages of the human African trypanosomiasis (sleeping sickness), caused by the Trypanosoma brucei gambiense strain of the parasite in patients aged 6 and older and weighing at least 20 kg, in 2021. Moreover, the major players in the regional market are investing huge capital to develop technologically advanced, effective, and easy-to-use sleep apnea devices.

It has been observed that changes in the lifestyle often lead to sleep disorders. In addition, the increasing consumption of tobacco, caffeine, and alcohol can affect the sleep cycle. Moreover, the high incidence of obesity, hypertension, cardiovascular diseases, and diabetes is fueling the growth of the market in the region. North America has several specialists and sleep centers, such as Carilion Clinic, Adam Moscovitch, Florida Lung, Asthma & Sleep Specialists, Oregon Sleep Associates, and Sound Sleep Health, which is a key reason the region has been lucrative for market players.

The market growth here is also attributed to the growing incidence of related disorders and increasing patient compliance for therapeutic drugs and devices. Additionally, the innovations in these products, along with the efforts to make citizens aware of apnea by different states, are boosting the growth of the U.S. market.

The Asia-Pacific market will witness the highest CAGR during the forecast period, of 7%. Various sleeping disorders, including insomnia, sleep apnea, restless leg syndrome, sleepwalking, and narcolepsy, require intervention, to prevent them from taking a serious form.

Moreover, products that help treat or manage sleep apnea remain in high demand, since a rising population in the region is experiencing obstructed breathing while sleeping.

Essentially, the industry revenue has been increasing in APAC due to the high consumption of sleeping pills as a result of the changing lifestyles, growing sleep disorder awareness, and long working hours. Further, due to the rise in the geriatric population, more people in the region are dealing with sleep-related problems than before, thus leading to an increase in the sale of sleeping aids.

Additionally, many organizations, such as the Indian Sleep Disorders Association (ISDA), Hong Kong Society of Sleep Medicine, and Asia-Pacific Pediatric Sleep Alliance, s have been creating awareness about sleep disorders. In particular, the ISDA conducts the Sleepcon conference to educate citizens on the newest concepts and trends in sleep disorder management every year.

The Chinese market for products that aid the sleep-deprived is growing at a high pace, especially with young people looking to increase the quantity and quality of their slumber. This propels the demand for smart mattresses, obstructive sleep apnea machines, and melatonin, a hormone that can induce sleep.

• North America (Largest Regional Market)
  • U.S. (Larger and Faster-Growing Country Market)
  • Canada
• Europe
  • Germany (Largest Country Market)
  • France (Fastest-Growing Country Market)
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific (APAC) (Fastest-Growing Regional Market)
  • China
  • Japan (Largest Country Market)
  • South Korea
  • India (Fastest-Growing Country Market)
  • Australia
  • Rest of APAC
• Latin America (LATAM)
  • Brazil (Largest and Fastest-Growing Country Market)
  • Mexico
  • Rest of LATAM
• Middle East and Africa (MEA)
  • Saudi Arabia (Largest Country Market)
  • South Africa
  • U.A.E. (Fastest-Growing Country Market)
  • Rest of MEA

Sleeping Aids Market Competitive Landscape

• The market is fragmented as a huge variety of products are used as sleeping aids, from the commonplace mattresses and pillows and OCT drugs to specialized prescription medication and cutting-edge medical devices.
• A large number of companies around the world offer pillows, mattresses, and OTC drugs, while even more firms, including local ones, provide herbal remedies, often over the internet.
• The market for sleep apnea devices and prescription drugs is slightly more consolidated; many prescription drugs have lost their patents and are, thus available in the generic form.
• Additionally, the whole ecosystem, including drugs as well as pillows & mattresses, is undergoing technological advancements, opening opportunities for more enterprises.
• Moreover, the market for services the most fragmented as there are a huge number of hospitals, clinics, and sleep laboratories around the world, as well as entities offering these services at people’s homes.

Sleeping Aids Market News & Updates

• In September 2024, Perfiby launched its 6-mg melatonin Sleep Aid Capsule, designed to offer restful sleep without any grogginess in the morning.
• In September 2024, Takeda Pharmaceutical Company Limited presented the results of the long-term extension study and phase 2 trials of its TAK-861 for the treatment of narcolepsy types 1 and 2. The presentation was given at Sleep Europe 2024, hosted by the European Sleep Research Society (ESRS) in Seville, Spain, on 24–27 September.
• In May 2024, Koninklijke Philips NV entered into a partnership to provide its remote patient monitoring solutions to all the departments of Radboud University Medical Center. The partnership also includes new software development, technical and repair services, and cybersecurity for the equipment.
• In April 2023, Cadwell Laboratories Inc. introduced Arc Voyager, a suite of remote monitoring solutions for people undergoing an EEG at home. The solution features the Arc 3.1 software, Arc Apollo+ wireless connectivity technology, an HD camera with autonomous infrared operations, tablet PC, microphone, and patient display.